CA1310642C - 2-amino-5-hydroxy-4-pyrimidones - Google Patents

2-amino-5-hydroxy-4-pyrimidones

Info

Publication number
CA1310642C
CA1310642C CA000571374A CA571374A CA1310642C CA 1310642 C CA1310642 C CA 1310642C CA 000571374 A CA000571374 A CA 000571374A CA 571374 A CA571374 A CA 571374A CA 1310642 C CA1310642 C CA 1310642C
Authority
CA
Canada
Prior art keywords
compound
formula
group
hydrogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000571374A
Other languages
English (en)
French (fr)
Inventor
Frederick J. Walker
John L. Lamattina
Brian T. O'neill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Application granted granted Critical
Publication of CA1310642C publication Critical patent/CA1310642C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Hydrogenated Pyridines (AREA)
CA000571374A 1987-07-09 1988-07-07 2-amino-5-hydroxy-4-pyrimidones Expired - Lifetime CA1310642C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US87/01608 1987-07-09
PCT/US1987/001608 WO1989000423A1 (en) 1987-07-09 1987-07-09 2-amino-5-hydroxy-4-pyrimidones

Publications (1)

Publication Number Publication Date
CA1310642C true CA1310642C (en) 1992-11-24

Family

ID=22202454

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000571374A Expired - Lifetime CA1310642C (en) 1987-07-09 1988-07-07 2-amino-5-hydroxy-4-pyrimidones

Country Status (12)

Country Link
EP (1) EP0303348B1 (enrdf_load_stackoverflow)
JP (1) JPH0629264B2 (enrdf_load_stackoverflow)
AT (1) ATE71370T1 (enrdf_load_stackoverflow)
CA (1) CA1310642C (enrdf_load_stackoverflow)
DE (1) DE3867563D1 (enrdf_load_stackoverflow)
DK (1) DK381188A (enrdf_load_stackoverflow)
ES (1) ES2037833T3 (enrdf_load_stackoverflow)
FI (1) FI883285A7 (enrdf_load_stackoverflow)
GR (1) GR3003908T3 (enrdf_load_stackoverflow)
IE (1) IE60210B1 (enrdf_load_stackoverflow)
PT (1) PT87944B (enrdf_load_stackoverflow)
WO (1) WO1989000423A1 (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
WO2013066729A1 (en) * 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
AP2014007637A0 (en) 2011-11-15 2014-05-31 Takeda Pharmaceutical Dihydroxy aromatic heterocyclic compound
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756189A (en) 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
US4153793A (en) * 1973-05-03 1979-05-08 Smith Kline & French Laboratories Limited Imidazo alkylamino pyrimidones
IN153791B (enrdf_load_stackoverflow) * 1979-03-10 1984-08-18 Soc D Etudes Prod Chimique
FR2503162A1 (fr) 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
GB8421427D0 (en) 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
DE3436380A1 (de) * 1984-10-04 1986-04-10 Bayer Ag, 5090 Leverkusen Selektiv-fungizide mittel auf pyrimidin-derivat-basis
JPS61205260A (ja) * 1985-03-08 1986-09-11 Zeria Shinyaku Kogyo Kk 新規な２−置換アミノ−６−（２−メトキシフエニ−ル）−４（３ｈ）−ピリミドン誘導体及びその製造法

Also Published As

Publication number Publication date
WO1989000423A1 (en) 1989-01-26
EP0303348A1 (en) 1989-02-15
FI883285A7 (fi) 1989-01-10
FI883285A0 (fi) 1988-07-08
JPS6429367A (en) 1989-01-31
IE60210B1 (en) 1994-06-15
PT87944A (pt) 1989-06-30
PT87944B (pt) 1995-03-01
JPH0629264B2 (ja) 1994-04-20
DE3867563D1 (en) 1992-02-20
EP0303348B1 (en) 1992-01-08
ES2037833T3 (es) 1993-07-01
IE882107L (en) 1989-01-09
DK381188A (da) 1989-02-21
DK381188D0 (da) 1988-07-08
GR3003908T3 (enrdf_load_stackoverflow) 1993-03-16
ATE71370T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
EP0193256B1 (en) Thiazolidinedione derivatives, their production and use
US4172896A (en) Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
EP0434561B1 (fr) Dérivés de la napht-1-yl pipérazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0138464A2 (en) 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
PL150617B1 (en) The method of production of new hydroxy- and alkoxypirimidine
US6359145B1 (en) Imidazole compounds
EP0249407A2 (en) Antiallergy and antiinflammatory agents
CA1310642C (en) 2-amino-5-hydroxy-4-pyrimidones
US5100910A (en) Aryl substituted tetrazole derivatives, and application thereof in therapeutics
US4824833A (en) Benzoxazine derivatives
US4940712A (en) Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
JPH07188197A (ja) オキサゾール誘導体
US3449357A (en) 2-((2,6-substituted)phenoxymethyl)-2-imidazolines
EP0638568B1 (fr) Pipérazines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant
US4910204A (en) 2-amino-5-hydroxy-4-pyrimidones
EP0319170A2 (en) Acyl derivatives of hydroxy pyrimidines
JP4501015B2 (ja) アミノピリミジン化合物の製造方法
KR20100046256A (ko) 치료 조성물
US5250551A (en) New (hetero)aryl substituted diazole derivatives, the method of preparing them and application thereof in therapeutics
HU202506B (en) Process for producing benzoxazolone derivatives
EP0702015B1 (en) Bicyclic oxazole and thiazole substituted ethers
PT99280B (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
US6861528B2 (en) Carboxylated heterocyclic compounds and methods of synthesis
EP0186275A2 (en) 2-Substituted amino-4(1H)-pyrimidone derivatives, their production, and medical compositions containing them
EP0588850A1 (en) LIPOXYGENASE INHIBITING N-HYDROYHANE DERIVATIVES.

Legal Events

Date Code Title Description
MKLA Lapsed